Sort   by:  
 Page size 
TranscriptomicsExpression profiling of 40 NSCLC cell lines
INTRODUCTION: CDKN2A (p16) inactivation is common in lung cancer and occurs via homozygous deletions, methylation of promoter region, or point mutations. Although p16 promoter methylation has been linked to KRAS mutation and smoking, the associations between p16 inactivation mechanisms and other com...
ORGANISM(S): Homo sapiens 
2015-06-22 | E-GEOD-63882 | biostudies-arrayexpress
Genomicsena-DATASET-Genentech-22-08-2012-06:56:27:875-9 - samples
Whole genome sequencing of SCLC tumor/normal samples
EGAD00001000221 | EGA
GenomicsLung normal control - samples
SCLC matched normal genotypes
EGAD00010000278 | EGA
GenomicsSmall Cell Lung Carcinoma - samples
SCLC tumor genotypes
EGAD00010000276 | EGA
Genomicsena-DATASET-Genentech-22-08-2012-07:03:30:871-10 - samples
Exome capture sequencing of SCLC tumor/normal pairs and cell lines
EGAD00001000222 | EGA
Genomicsena-DATASET-Genentech-22-08-2012-07:05:26:504-11 - samples
RNA sequencing of SCLC tumor/normal sample pairs and cell lines
EGAD00001000223 | EGA
GenomicsGenentech Small Cell Lung Cancer (SCLC) Screen
Exome capture, RNA-Seq, whole genome sequencing of set of Small Cell Lung Cancer samples.
EGAS00001000334 | EGA
Sort   by:  
 Page size